Chronic Pain Costs America $723 Billion a Year as Millions Miss Evidence-Based Care

America spends about $723 billion a year on chronic pain, yet millions of patients still get the wrong kind of care.

Story Snapshot

Chronic pain now costs the U.S. an estimated $722.8 billion per year in care and lost work.
Over 50 million adults live with chronic pain, making it one of the country’s most common health problems.
Evidence-based guidelines call for more non-drug treatments, but most patients still get pills, procedures, and surgery first.
Both right and left can see chronic pain as another example of a health system that serves money and bureaucracy over patients.

Chronic Pain’s Massive Price Tag

Researchers estimate that chronic pain cost the United States about **$722.8 billion** in 2021 alone. That total includes around $530.6 billion in medical care and $192.2 billion in lost work productivity. Adults with chronic pain paid about $8,068 more in medical bills each year and lost about $2,923 in income compared with people without pain. Earlier national studies placed the yearly cost of chronic pain between $560 and $635 billion, showing this is not a new problem.

Chronic pain is not rare or exotic; it is now everyday reality for tens of millions of Americans. The Centers for Disease Control and Prevention (CDC) reports that about 20.9% of adults—around 51.6 million people—had chronic pain in 2021. Other reviews describe more than 50 million Americans living with ongoing pain and call it a “silent public health epidemic.” Chronic pain affects more people than cancer, heart disease, or diabetes and drives more health spending than these major illnesses.

How Care Goes Wrong Despite Clear Guidelines

Federal reports and medical guidelines have, for years, urged doctors to use more non-drug approaches for chronic pain, such as physical therapy, exercise, counseling, and other behavioral treatments. Yet most patients still receive medications—especially opioids—procedures, and surgery as the first and often only line of care. One claims analysis found that fewer than 12% of people with chronic low back pain received the behavioral and psychological treatments that clinical guidelines recommend. This pattern shows a wide gap between what science says and what patients actually get.

This gap does not appear by accident. Studies of chronic pain spending find that per-patient health care costs are much higher for those treated with opioid-heavy paths than for those who avoid those drugs. Expensive procedures, imaging tests, injections, and surgeries bring in more money for hospitals and clinics than time-intensive therapies like coaching, physical therapy, or group pain programs. As a result, the system rewards quick prescriptions and interventions even when they offer only short-term relief and higher risk, including addiction and overdose. Patients pay the price through repeated visits, side effects, and ongoing disability.

What This Means for Workers, Families, and Taxpayers

Lost work productivity from chronic pain is a huge part of the national bill, ranging from roughly $297 to $336 billion per year in older estimates. Many workers with pain do not stay home; they show up but cannot perform at full speed, a problem known as presenteeism. One study found that common pain conditions led to $61 billion each year in lost productivity, with about 77% due to reduced performance rather than missing work. Chronic pain also raises the odds that people leave the workforce altogether because of poor health.

These losses ripple through families. When a parent or caregiver lives with chronic pain, household income drops and stress rises. Some spouses miss work to help, creating more lost wages. Federal programs like Medicare carry a large share of the medical cost, with one report estimating that pain-related care made up about one-quarter of Medicare spending in 2008. That means taxpayers are funding a system that spends heavily on chronic pain while often failing to give people care that actually restores function and independence.

Why Chronic Pain Fuels Distrust Across the Political Spectrum

For many Americans—conservative and liberal alike—chronic pain care looks like another case where the system works better for big institutions than for ordinary people. Conservatives who worry about government waste can point to hundreds of billions spent every year, while guideline-based, lower-cost treatments remain hard to access or poorly covered by insurance. Liberals who fear growing inequality see millions of low-income and minority patients with pain who cannot afford multidisciplinary care and are more likely to be offered quick prescriptions instead.

Pain advocates and policy experts argue that the country could spend less and help people more by changing incentives. They call for expanding insurance coverage to include all evidence-based pain services, making peer support a standard part of care, and paying clinics based on patient outcomes instead of visit volume. These ideas cut across party lines: they aim to reduce waste, reward effective care, and give patients real options beyond pills and surgeries. Yet, just as with many other issues, federal action has been slow and fragmented, even as the economic burden grows.